ClinConnect ClinConnect Logo
Search / Trial NCT04200664

Audiovestibular Function in Infratentorial Superficial Siderosis

Launched by UNIVERSITY COLLEGE, LONDON · Dec 13, 2019

Trial Information

Current as of April 30, 2025

Completed

Keywords

Superficial Siderosis, Infratentorial Nervous System Diseases Hearing Loss Hearing Tests Auditory Pathways Vestibulocochlear Nerve Ataxia Vestibular Function Tests Biomarkers Central Nervous System

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Siderosis group: adults (male and female) of 18+ years old with a known diagnosis of iSS (defined using standardised radiological criteria) confirmed by a consultant neurologist with expertise in this condition at University College London Hospitals National Health Service (NHS) Foundation Trust
  • Age-related hearing loss (ARHL) group: adults (male and female) of 18+ years old with ARHL
  • Control group: adults (male and female) of 18+ years old with no previous diagnosis of hearing loss or no known neurological disorder (including iSS) that affects hearing, with the aim to recruit such participants of 50 years of age and above; however, should difficulty with the recruitment of such participants arise, participants of 18 years of age and above will be invited to participate in the study.
  • Exclusion Criteria:
  • All groups: individuals younger than 18 years old; individuals with a physical or mental impairment that prevents the potential participant from giving informed consent or undergoing the hearing and/or vestibular assessment;
  • Siderosis group: individuals with no prior diagnosis of iSS
  • Age-related hearing loss (ARHL) group: individuals with no previous diagnosis of ARHL or with a diagnosis of hearing loss of aetiology other than age-related; individuals with a history of exposure to high-intensity noise or ototoxic drugs or evidence of middle ear disease/dysfunction or family history of non age-related hearing loss;
  • Control group: individuals with a known history of hearing loss (of any cause) or with a known neurological disorder that affects their hearing; individuals with history of exposure to high-intensity noise or ototoxic drugs or evidence of middle ear disease or family history of non age-related hearing loss;

About University College, London

University College London (UCL) is a leading global research institution renowned for its commitment to advancing healthcare through innovative clinical trials. As a prominent sponsor of clinical research, UCL leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous investigations aimed at improving patient outcomes and addressing pressing medical challenges. The institution fosters collaboration among researchers, healthcare professionals, and industry partners, ensuring that its trials adhere to the highest ethical standards and regulatory guidelines. UCL's dedication to translating scientific discoveries into practical applications underscores its role as a vital contributor to the advancement of medical science and public health.

Locations

London, , United Kingdom

London, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Doris-Eva Bamiou, Professor

Principal Investigator

The Ear Institute, University College London; Department of Neuro-otology, University College London Hospitals NHS Foundation Trust, UK

David J Werring, Professor

Principal Investigator

Department of Brain Repair and Rehabilitation, Stroke Research Centre, Institute of Neurology, University College London; Department of Neurology, University College London Hospitals NHS Foundation Trust, UK

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials